JF
PDSB icon

Jump Financial’s PDS Biotechnology PDSB Stock Holding History

Jump Financial’s Portfolio PDSB Stock Details PDSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-17,100
Closed -$86.4K – 2121
2023
Q3 		$86.4K Sell
17,100
-75,300
-81% -$412K ﹤0.01% 1697
2023
Q2 		$465K Buy
92,400
+23,929
+35% +$157K 0.02% 1068
2023
Q1 		$421K Buy
68,471
+44,341
+184% +$363K 0.02% 979
2022
Q4 		$319K Buy
+24,130
New +$170K 0.02% 1002
2022
Q1 		– Sell
-34,902
Closed -$283K – 1821
2021
Q4 		$283K Buy
34,902
+8,478
+32% +$91.2K 0.02% 919
2021
Q3 		$393K Buy
+26,424
New +$329K 0.03% 553

Other funds holding PDSB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JFG
Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $874M AUM 16.23% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jump Financial's PDSB Position: Q4 2023 in Review

Jump Financial sold out of PDS Biotechnology (PDSB) in Q4 2023, closing a stake of 17,100 shares — an estimated $86.4K sold.

Jump Financial first reported a position in PDSB in Q3 2021 and held it in 6 quarters. The position peaked at $465K in Q2 2023. 77 funds tracked by Wall St. Rank hold PDSB as of Q4 2023.

  • Jump Financial reported no remaining PDS Biotechnology position as of Q4 2023 after selling out during the quarter.
  • Jump Financial sold 17,100 PDS Biotechnology shares in Q4 2023, an estimated $86.4K.
  • Jump Financial first reported a position in PDS Biotechnology in Q3 2021 and held it in 6 quarters.
  • Jump Financial's PDS Biotechnology position peaked at $465K in Q2 2023.
  • 77 funds tracked by Wall St. Rank held PDS Biotechnology as of Q4 2023.

Based on Jump Financial's 13F filing for Q4 2023, filed 7 Feb 2024.